(Society for Maternal-Fetal Medicine) Researchers with The PRESERVE-1 Study Group University of Texas Health Science Center at Houston--McGovern Medical School, Houston, Texas, and Yale School of Medicine, New Haven, Connecticut, present findings of a study titled Randomized double-blind placebo controlled evaluation of the safety and efficacy of recombinant Antithrombin versus placebo in preterm preeclampsia. The study was sponsored by rEVO Biologics, Inc.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2jU5q1L
No comments:
Post a Comment